2,7-Dibromo-10-(2-pyridyl)-12,13-dihydro-11Н-dibenzo[f,h]cyclopenta[c]quinoline (6a). Yield
1.00 g (80%), colorless crystals, mp 242-244°C. 1H NMR spectrum, δ, ppm (J, Hz): 2.22-2.26 (2Н, m, 12-CH2);
3
3.59-3.63 (4Н, m, 11,13-CH2); 7.34-7.38 (1H, m, H-5 Рy); 7.71-7.75 (2Н, m, Н-3,6); 7.94 (1Н, ddd, J = 7.5,
4
3
3
3
3J = 7.5, J = 1.8, Н-4 Рy); 8.28 (1Н, d, J = 8.8, Н-4); 8.38 (1Н, d, J = 8.8, Н-5); 8.59 (1Н, dd, J = 7.5,
4J = 1.2, Н-3 Рy); 8.68 (1Н, d, J = 1.8, Н-1); 8.75 (1Н, dd, J = 4.9, J = 1.8, Н-6 Py); 9.49 (1Н, d, J = 1.8,
Н-8). Mass spectrum, m/z (Irel, %): 505 [М+Н]+ (50). Found, %: C 59.44; H 2.97; N 5.50. C25H16Br2N2.
Calculated, %: C 59.55; H 3.20; N 5.56.
4
3
4
4
3,6-Dibromo-10-(2-pyridyl)-12,13-dihydro-11Н-dibenzo[f,h]cyclopenta[c]quinoline (6b). Yield
1.03 g (82%), colorless crystals, mp 202-204°C. 1H NMR spectrum, δ, ppm (J, Hz): 2.23-2.27 (2Н, m, 12-CH2);
3
4
3.60-3.64 (4Н, m, 11,13-CH2); 7.34-7.38 (1H, m, H-5 Рy); 7.74 (1Н, dd, J = 8.8, J = 1.6, Н-2); 7.79 (1Н, dd,
4
3J = 8.8, J = 1.6, Н-7); 7.92 (1Н, ddd, 3J = 7.5, 3J = 7.5, 4J = 1.8, Н-4 Рy); 8.45 (1Н, dd, 3J = 7.5, 4J = 1.2, Н-3
Рy); 8.56-8.62 (2Н, m, Н-1,4); 8.66 (1Н, d, 4J = 1.6, Н-5); 8.75 (1Н, dd, 3J = 4.9, 4J = 1.8, Н-6 Рy); 9.30 (1Н, d,
3J = 8.8, Н-8). 13С NMR spectrum, δ, ppm: 25.7; 33.3; 37.2; 121.8; 122.1; 123.1 (2С); 123.6; 125.0; 126.0;
127.9; 128.9; 129.0; 130.0; 130.5; 130.7; 130.8; 131.1; 136.4; 139.5; 143.8; 148.6; 150.4; 151.7; 158.4. Mass
spectrum, m/z (Irel, %): 505 [М+Н]+ (50). Found, %: C 59.51; H 3.01; N 5.43. C25H16Br2N2. Calculated, %:
C 59.55; H 3.20; N 5.56.
6,11-Diiodo-2-(2-pyridyl)phenanthro[9,10-b]pyridine (6c). Triazatriphenylene 3c (0.5 g, 0.89 mmol) was
suspended in 1,2-dichlorobenzene (40 ml). 2,5-Norbornadiene (0.27 ml, 2.67 mmol) was added, and the mixture was
refluxed for 35 h while adding 2,5-norbornadiene (0.27 ml, 2.67 mmol) every 8 h. The solvent was removed by
distillation under vacuum, the residue was purified by column chromatography (eluent 3:1 CH2Cl2–EtOAc, Rf 0.2).
1
Yield 200 mg (40%), light-yellow crystals, mp >250°C. H NMR spectrum, δ, ppm (J, Hz): 7.51-7.55 (1H, m,
3
4
H-5 Рy); 8.05-8.09 (3Н, m); 8.56-8.60 (2Н, m); 8.75-8.79 (3Н, m); 9.15 (1Н, dd, J = 4.9, J = 1.8, Н-6 Рy);
9.31 (1Н, d, 3J = 8.8, Н-4); 9.70 (1Н, d, 4J = 1.8, Н-12). Mass spectrum, m/z (Irel, %): 559 [М+Н]+ (100). Found,
%: C 47.01; H 1.93; N 4.87. C22H12I2N2. Calculated, %: C 47.34; H 2.17; N 5.02.
Preparation of Monoazatriphenylene Aryl Derivatives 7a-d (General Method). A solution of
dibromomonoazatriphenylene 6a,b (0.50 mmol) in toluene (25 ml) was treated with the boronic acid 8a,b
(1.05 mmol), PdCl2(PPh3)2 complex (18 mg, 25 µmol), and PPh3 (13 mg, 50 µmol). Separately a solution of
K2CO3 (1.38 g, 10.00 mmol) in distilled water (20 ml) was prepared and added to the reaction mixture. Ethanol
(10 ml) was added, and the mixture was stirred under argon atmosphere at 85°C for 7 h. The organic phase was
separated, washed with K2CO3 and NH4Cl solutions, then dried over anhydrous Na2SO4. The solvents were
removed by distillation under vacuum, and the residue was recrystallized from toluene.
2,7-Diphenyl-10-(2-pyridyl)-12,13-dihydro-11Н-dibenzo[f,h]cyclopenta[c]quinoline (7а). Yield 180
1
mg (72%), colorless crystals, mp 270-272°C. H NMR spectrum, δ, ppm (J, Hz): 2.24-2.28 (2Н, m, 12-CH2);
3
3
3.64 (2Н, t, J = 7.5, 11-CH2); 3.78 (2Н, t, J = 7.5, 13-CH2); 7.32-7.36 (1H, m, H-5 Py); 7.41-7.45 (2H, m,
3
H Ph); 7.51-7.57 (4H, m); 7.77-7.81 (2H, m); 7.86-7.97 (5H, m); 8.63 (1Н, d, J = 8.8, Н-4); 8.65 (1Н, dd,
3J = 7.5, J = 1.2, Н-3 Рy); 8.72 (1Н, d, J = 8.8, Н-5); 8.75 (1Н, dd, J = 4.9, J = 1.8, Н-6 Рy); 8.85 (1Н, d,
4
3
3
4
4J = 1.6, Н-1); 9.71 (1Н, d, J = 2.0, Н-8). 13С NMR spectrum, δ, ppm: 26.0; 33.3; 37.4; 122.7; 122.9; 123.4;
4
123.6; 123.8; 124.3; 126.0; 126.2; 127.2 (2C); 127.3; 127.4; 128.8; 129.0; 129.6; 130.0; 130.5; 132.1; 132.3;
136.3; 139.1; 139.2; 139.8; 141.1; 141.4; 145.2; 148.4; 150.4; 151.8; 158.9. Mass spectrum, m/z (Irel, %): 499
[М+Н]+ (100). Found, %: C 88.97; H 5.11; N 5.43. C37H26N2. Calculated, %: C 89.13; H 5.26; N 5.62.
2,7-Bis(3,4,5-trimethoxyphenyl)-10-(2-pyridyl)-12,13-dihydro-11Н-dibenzo[f,h]cyclopenta[c]quino-
line (7b). Yield 230 mg (68%), colorless crystals, mp 236-238°C. 1H NMR spectrum, δ, ppm (J, Hz): 2.27-2.31
(2Н, m, 12-CH2); 3.67 (2Н, t, 3J = 7.5, 11-CH2); 3.82 (2Н, t, 3J = 7.5, 13-CH2); 3.95 (3H, s, OCH3); 3.96 (3H, s,
OCH3); 4.01 (6H, s, 2OCH3); 4.02 (6H, s, 2OCH3); 6.99 (2H, s, Н Ar); 7.08 (2H, s, Н Ar); 7.33-7.37 (1H, m,
H-5 Py); 7.85-7.96 (3H, m, H-3,6, H-4 Py); 8.65 (1Н, d, 3J = 8.5, Н-4); 8.69 (1Н, dd, 3J = 7.5, 4J = 1.2, Н-3 Py);
8.73-8.77 (2H, m, Н-5, Н-6 Py); 8.85 (1Н, d, 4J = 1.6, Н-1); 9.72 (1Н, d, 4J = 2.0, Н-8). 13С NMR spectrum, δ,
ppm: 26.2; 33.3; 37.4; 53.7; 56.3; 56.4; 61.0; 104.8; 104.9; 123.0; 123.4; 123.5; 123.8; 124.3; 125.3; 126.1;
126.3; 127.3; 129.6; 130.0; 130.5; 132.0; 135.3; 136.3; 137.0; 137.2; 138.0; 138.2; 139.3; 139.4; 140.0; 145.1;
877